Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Seung Hyeun Lee

Osimertinib for Secondary T790m-Mutation–Positive Squamous Cell Carcinoma Transformation After Afatinib Failure

Journal of Thoracic Oncology

English

Back Cover: In‐Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid Toward the Biomarker Discovery for Lung Cancers

Proteomics - Clinical Applications

Clinical Biochemistry

2019

English

Related publications

Squamous Cell Carcinoma “Transformation” Concurrent With Secondary T790M Mutation in Resistant EGFR -Mutated Adenocarcinomas

Journal of Thoracic Oncology

English

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

PLoS ONE

Multidisciplinary

2019

English

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.13-23 Osimertinib Treatment Result of Plasma T790M Positive in Different Clinical Failure Modes After First-Line EGFR TKI for EGFR Mutant NSCLC

Journal of Thoracic Oncology

English

OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Journal of Thoracic Oncology

English

Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology

Oncology

2017

English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

English

P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas V2 After Acquired Resistance to Afatinib

Journal of Thoracic Oncology

English

Osimertinib Plus Durvalumab Versus Osimertinib Monotherapy in EGFR T790m-Positive NSCLC Following Previous EGFR-TKI Therapy: CAURAL Brief Report

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Seung Hyeun Lee

Osimertinib for Secondary T790m-Mutation–Positive Squamous Cell Carcinoma Transformation After Afatinib Failure

Back Cover: In‐Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid Toward the Biomarker Discovery for Lung Cancers

Related publications

Squamous Cell Carcinoma “Transformation” Concurrent With Secondary T790M Mutation in Resistant EGFR -Mutated Adenocarcinomas

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

P2.13-23 Osimertinib Treatment Result of Plasma T790M Positive in Different Clinical Failure Modes After First-Line EGFR TKI for EGFR Mutant NSCLC

OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

P072 Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by Cobas V2 After Acquired Resistance to Afatinib

Osimertinib Plus Durvalumab Versus Osimertinib Monotherapy in EGFR T790m-Positive NSCLC Following Previous EGFR-TKI Therapy: CAURAL Brief Report